Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alcobra Ltd (NASDAQ:ADHD)

0.9999
Delayed Data
As of Aug 21
 -0.0201 / -1.97%
Today’s Change
0.83
Today|||52-Week Range
5.36
-52.39%
Year-to-Date
No recent news for Alcobra Ltd.

Today’s Trading

Previous close1.02
Today’s open0.98
Day’s range0.94 - 1.01
Volume101,952
Average volume (3 months)205,189
Market cap$28.1M
Dividend yield--
Data as of 08/21/2017

Growth & Valuation

Earnings growth (last year)+1.11%
Earnings growth (this year)+43.82%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.60

Competitors

 Today’s
change
Today’s
% change
VKTXViking Therapeutics ...+0.01+0.99%
CATBCatabasis Pharmaceut...-0.01-0.81%
VICLVical Inc-0.09-3.70%
AMPEAmpio Pharmaceutical...+0.07+15.66%
Data as of 08/21/2017

Financials

Next reporting dateNovember 15, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$0.00
Annual profit (last year)-$24.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
David C. Baker
Chief Operating Officer &
Chief Financial Officer
Tomer Berkovitz
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts